Live Breaking News & Updates on Parkman healthcare partners

Stay informed with the latest breaking news from Parkman healthcare partners on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Parkman healthcare partners and stay connected to the pulse of your community

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Short Interest Update

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 1,050,000 shares, a decrease of 15.3% from the March 31st total of 1,240,000 shares. Based on an average daily volume of 341,300 shares, […]

Chicago , Illinois , United-states , Acumen-pharmaceuticals , Jump-financial , Acumen-pharmaceuticals-company-profile , Acumen-pharmaceuticals-trading , News-ratings-for-acumen-pharmaceuticals-daily , Acumen-pharmaceuticals-inc , Franklin-resources-inc , Parkman-healthcare-partners

Morgan Stanley Reiterates "Overweight" Rating for Silence Therapeutics (NASDAQ:SLN)

Morgan Stanley Reiterates "Overweight" Rating for Silence Therapeutics (NASDAQ:SLN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Parkman-healthcare-partners , Vivo-capital , Morgan-stanley , Sg-americas-securities , Silence-therapeutics , Free-report , Therapeutics-trading-down , Get-free-report , Healthcare-partners , Oligonucleotide-discovery , Silence-therapeutics-daily

Syndax Pharmaceuticals' (SNDX) "Buy" Rating Reaffirmed at HC Wainwright

Syndax Pharmaceuticals' (SNDX) "Buy" Rating Reaffirmed at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Scotiabank , Syndax-pharmaceuticals-inc , Syndax-pharmaceuticals-stock-performance , Nasdaq , Analyst-recommendations-for-syndax-pharmaceuticals , News-ratings-for-syndax-pharmaceuticals-daily , Parkman-healthcare-partners , Syndax-pharmaceuticals , Vanguard-group-inc , Jpmorgan-chase-co , Institutional-investors-weigh-in-on-syndax-pharmaceuticals

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Forecasted to Post Q2 2024 Earnings of ($0.06) Per Share

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Forecasted to Post Q2 2024 Earnings of ($0.06) Per Share
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Sanjk-patel , Michaelr-megna , Nasdaq , News-ratings-for-kiniksa-pharmaceuticals-daily , Kiniksa-pharmaceuticals-company-profile , Kiniksa-pharmaceuticals-ltd , Granahan-investment-management , Institutional-trading-of-kiniksa-pharmaceuticals , Parkman-healthcare-partners , Opaleye-management-inc , Allspring-global-investments-holdings

Evercore ISI Boosts Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30.00

Evercore ISI Boosts Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Michaelr-megna , Kiniksa-pharmaceuticals-stock-performance , Kiniksa-pharmaceuticals-ltd , Allspring-global-investments-holdings , Hennion-walsh-asset-management-inc , Securities-exchange-commission , Nasdaq , Institutional-trading-of-kiniksa-pharmaceuticals , Kiniksa-pharmaceuticals-company-profile , Kiniksa-pharmaceuticals , News-ratings-for-kiniksa-pharmaceuticals-daily

Cullinan Oncology (NASDAQ:CGEM) Trading 7.8% Higher

Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report)’s stock price shot up 7.8% on Wednesday . The stock traded as high as $18.24 and last traded at $17.97. 153,899 shares were traded during trading, a decline of 68% from the average session volume of 477,343 shares. The stock had previously closed at $16.67. Wall Street […]

United-states , William-blair , Corrine-savill , Cullinan-oncology-inc , Franklin-resources-inc , Cullinan-oncology-company-profile , Affinity-asset-advisors , Securities-exchange-commission , Quest-partners , Nasdaq , Parkman-healthcare-partners , Investment-management

Quanterix (NASDAQ:QTRX) Trading Down 3.6%

Quanterix (NASDAQ:QTRX) Trading Down 3.6%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Los-angeles , California , United-states , America , Lauriej-olson , Asia-pacific , Quanterix-co , Los-angeles-capital-management , Scotiabank , Quanterix-corporation , Nasdaq , Quanterix-company-profile

Brokerages Set Quanterix Co. (NASDAQ:QTRX) Price Target at $32.00

Shares of Quanterix Co. (NASDAQ:QTRX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the six ratings firms that are presently covering the company, MarketBeat reports. Five equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average […]

United-states , Los-angeles , California , America , Asia-pacific , Lauriej-olson , Securities-exchange-commission , Quanterix-co , Quanterix-corporation , Scotiabank , Nasdaq , Parkman-healthcare-partners

Brokerages Set Quanterix Co. (NASDAQ:QTRX) Target Price at $32.00

Brokerages Set Quanterix Co. (NASDAQ:QTRX) Target Price at $32.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Los-angeles , California , United-states , America , Lauriej-olson , Asia-pacific , Quanterix-co , Allspring-global-investments-holdings , Parkman-healthcare-partners , Quanterix-corporation , Los-angeles-capital-management , Nasdaq

Nuvalent, Inc. (NASDAQ:NUVL) Receives $90.00 Consensus PT from Brokerages

Shares of Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the ten research firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1 […]

Robertw-baird , Matthew-shair , Nuvalent-inc , Nasdaq , Renaissance-capital , Vanguard-group-inc , Nuvalent-company-profile , Perceptive-advisors , Parkman-healthcare-partners , Jpmorgan-chase-co , Allspring-global-investments-holdings , Get-free-report